相关实验视频
Updated: Jun 18, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
64
微RNA-19b通过促进Th9细胞加剧全身性硬化症
Yun-Ji Lim1, Sang-A Park1, Dandan Wang2
1Mucosal Immunology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD 20892, USA.
Cell reports
|July 31, 2024
概括
微RNA-19b促进T辅助9细胞,恶化系统性硬化症 (SSc). 抑制miR-19b可以改善小鼠的SSc,这表明这种自身免疫性疾病的治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病,其特征是广泛的纤维化.
- 精确的免疫机制驱动SSc的发病机制尚未完全理解.
研究的目的:
- 研究微RNA-19b (miR-19b) 在SSc.的发展和进展中的作用.
- 阐明miR-19b通过哪些分子途径影响SSc.中的T助手9 (Th9) 细胞活性.
主要方法:
- 使用了白胺诱导的SSc.小鼠模型.
- 分析了miR-19b和IL-9表达的CD4+T细胞.
- 研究了涉及TGF-β,IL-4,NLRC3,TRAF6,TAK1,NF-κB和E2f8.8.B的分子机制.
- 与SSc患者的疾病严重程度相关的miR-19b和IL-9水平.
主要成果:
- 在实验性SSc中,miR-19b和IL-9水平在CD4+T细胞中升高.
- 在小鼠中,抑制miR-19b减少了Th9细胞并改善了SSc症状.
- 确定了一条涉及TGF-β,IL-4,NLRC3,TRAF6,TAK1和NF-κB的分子通路,导致miR-19b上调.
- miR-19b通过抑制E2f8.8直接提高IL-9的调节.
- 在SSc患者中增加IL-9和MIR-19B水平与疾病严重程度相关.
结论:
- miR-19b 是 Th9 细胞驱动的 SSc 病变发生的关键媒介.
- 向miR-19b为管理SSc.提供了一个潜在的治疗战略.
相关概念视频
T Cell Types and Functions
967
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
967
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K

